Sekisui Chemical Co., Ltd. - Investment in PeptiStar Inc.

Leading Japanese law firm Nishimura & Asahi has advised Sekisui Chemical Co., Ltd. (“Sekisui”) on its additional investment in joint-venture company PeptiStar Inc. (“PeptiStar”). PeptiStar expects to raise additional funds from 17 investors, including Sekisui, PeptiDream Inc. (“PeptiDream”), Shionogi & Co., Ltd. (“Shionogi”) and Innovation Network Corporation of Japan.

In 2017, Sekisui, PeptiDream and Shionogi formed PeptiStar to set up a contract manufacturing organization for research, development, manufacturing, and commercialization of peptide therapeutics.

Sekisui [TYO: 4204], established in 1947 and headquartered in Osaka, Japan, is a developer of plastic-mold processes and new materials and technologies, and offers a vast array of products and services in fields ranging from housing and urban infrastructure to the electronics, automotive, and other advanced-technology fields around the world.

The Nishimura & Asahi team advising Sekisui was led by partners Takuya Matsuo and Tatsuya Nakayama.